Japan IR Japanese Corporate IR Information - Clear, Accessible

#Schizophrenia

List of IR information related to "Schizophrenia".

1 IR Posts

1 Companies

Today Last Updated

1 IR Posts

4565 Nexera Pharma Corporation

2026/04/13

Announcement of Subject Dosing Start in Phase 2 Trial of NBI-1117570 for Adult Schizophrenia Patients by Partner NeuroCline, Inc.

Partner NeuroCline, Inc. has initiated a Phase 2 trial of NBI-1117570 targeting adult schizophrenia patients and received a 22.5 million USD milestone payment.

#NexeraPharma #NewDrugDevelopment #Schizophrenia

#Schizophrenia

Filters